CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 48 enrolled
Drug / intervention
LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical geldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04203225
NCT04203225Phase 4Completed
CompareCT.gov

Comparison of 2 Application Techniques for LET (Lidocaine 4%; Epinephrine 0.1%; Tetracaine 0.5%) Gel Used Prior to Simple Laceration Repair in Children

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·interventional·Posted Dec 18, 2019·Updated Feb 18, 2021

In Brief

A Phase 4 clinical trial evaluating LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel for Lacerations and 2 related conditions. Completed, enrolled 48 participants across 2 sites.

Detailed Summary

Comparison of anesthetic efficacy of Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel (LET) applied three times for 10 minutes each time vs. once for 30 minutes prior to suturing simple lacerations in children aged 7-17 years.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLacerations, Pain, Procedural, LET
CountriesUnited States
CollaboratorsChildren's Hospital of Orange County

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedDec 18, 2019
Enrollment StartMay 22, 2017
Primary CompletionNov 12, 2019
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 6.5 years ago

Interventions

LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical geldrug

Topical anesthetic